4 min read
Journal round-up: Value in Health 24(12)
Our authors provide regular round-ups of the latest peer-reviewed journals. We cover all issues of major health economics journals as well as other
Tag : Real World Evidence
4 min read
3 min read
EVERSANA and Integra Connect Form Strategic Partnership
EVERSANA and Integra Connect Form Strategic Partnership to Advance Next Generation Oncology Commercialization Services Propelled by Real-World
2 min read
FDA Greenlights Bristol Myers Squibb’s Orencia for Acute GVHD – Partly on RWE
FDA Greenlights BMS’s Orencia for Acute GVHD – Partly on RWE Published: Dec 15, 2021 By Alex Keown BioSpace Bristol Myers Squibb’s
1 min read
Bionano Genomics Acquiring BioDiscovery – The Perfect Alignment of the Stars
One of October’s headlines in the field of genomics and genetics included the acquisition of BioDiscovery by Bionano Genomics. I spoke with
1 min read
Real-world evidence and qualitative research: the ELICIT podcast
In the first episode of the ELICIT podcast, a new series produced in partnership with Cerner Enviza, the speakers discuss qualitative real-world
FDA Draft Guidance for Real-world Data: Documentation of Data Approach Is Key
Oct. 25, 2021 – Translating real-world data (RWD) into a standard format that the Food and Drug Administration (FDA) can process, review and
1 min read
FDA Issues Draft Guidance on RWD Sourced from EHRs and Medical Claims Data
In late September 2021, the United States Food and Drug Administration (FDA) issued draft guidance, Real-World Data: Assessing Electronic Health
Comment Now on FDA Draft Guidance on Use of EHR, Claims Data as RWD
Oct. 4, 2021 – As part of its real-world evidence (RWE) program, the Food and Drug Administration last week issued a draft guidance to provide
1 min read
Extracting Oncology Insights From Real-world Clinical Data With NLP
Preview the solution accelerator notebooks referenced in this blog online or get started right away by downloading and importing the notebooks into
FDA Shares Drug Review Priorities, Sets Date for Public Meeting
Sept. 10, 2021 – The Food and Drug Administration (FDA) recently issued a commitment letter regarding the next iteration of the Prescription Drug
Leading Real-World Data and Analytics Organizations Form Industry Coalition to Advance Policies to Support Regulatory Use of Real-World Evidence
RWE Alliance Launched by Aetion, Flatiron Health, IQVIA, Syapse, and Tempus May 19, 2021 07:00 AM Eastern Daylight Time WASHINGTON–(BUSINESS
1 min read
FAIR Data or the Journey Towards Data-Centricity – Pushing Towards Making Data Discoverable, Accessible, Interoperable, and Reusable
Data is the blood being pumped through the organism of personalized medicine and will be – as has always been – the key to the identification of
4 min read
CDRH Report Provides Examples of Real-World Evidence in Medical Device Regulatory Decisions
Recently, the United States Food and Drug Administration’s (FDA) Center for Devices and Radiological Health (CDRH) issued a report that provides an
4 min read
CDRH Report Provides Examples of Real-World Evidence in Medical Device Regulatory Decisions
Recently, the United States Food and Drug Administration’s (FDA) Center for Devices and Radiological Health (CDRH) issued a report that provides an
4 min read
The rise of real-world evidence: unlocking the potential in EHRs
The COVID-19 pandemic has demonstrated the importance of health data and how its availability in real time can reveal new insights and innovations